- Cello Health said it had sold Pulsar, the social media analytics software business, to Access Intelligence for £4.5m in a shares-only deal.

The disposal of Pulsar would allow the group to ‘focus its capital investment on its higher growth and higher margin healthcare business as well as supporting the development of the core Signal business,’ the company said.

Under the sale agreement, Access Intelligence agreed to issue 8,653,846 ordinary shares and a pay £1 in cash to Cello.

‘Cello will continue to make use of Pulsar in partnership with Access Intelligence where there is mutual client opportunity,’ the company said.

For the year ended 31 December 2018, Pulsar generated unadjusted losses before tax of £1.0m from unaudited revenues of £7.0m and, as at 30 June 2019, had gross assets of £3.2m.

At 9:44am: [LON:CLL] Cello Group PLC share price was +1p at 128p

Story provided by